209 related articles for article (PubMed ID: 1495661)
1. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
Lewis-Barned NJ; Ball MJ
N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
Leclercq V; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
[TBL] [Abstract][Full Text] [Related]
4. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
6. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin.
Chisholm A; Mann J; Sutherland W; Williams S; Ball M
Q J Med; 1992; 85(307-308):825-31. PubMed ID: 1484945
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
[TBL] [Abstract][Full Text] [Related]
8. A one-year multicentre study of simvastatin in the treatment of hypercholesterolaemia. UK and Eire Simvastatin Study Group.
Br J Clin Pract; 1994; 48(5):231-5. PubMed ID: 7917813
[TBL] [Abstract][Full Text] [Related]
9. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.
de Graaf J; Demacker PN; Stalenhoef AF
Neth J Med; 1993 Dec; 43(5-6):254-61. PubMed ID: 8107933
[TBL] [Abstract][Full Text] [Related]
10. [Simvastatin in the treatment of familial hypercholesterolemia].
Ceska R; Sobra J; Procházková R; Kvasilová M
Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
12. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
13. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
[TBL] [Abstract][Full Text] [Related]
14. [Simvastatin in the treatment of hypercholesterolemia].
Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
[TBL] [Abstract][Full Text] [Related]
15. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor.
Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL
Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613
[TBL] [Abstract][Full Text] [Related]
17. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
Kehely A; MacMahon M; Barbir M; Wray R; Hunt BJ; Prescott RJ; Thompson GR
QJM; 1995 Jun; 88(6):421-7. PubMed ID: 7648234
[TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
Darioli R; Bovet P; Brunner HR; Bercher L
Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
Stuyt PM; Mol MJ; Stalenhoef AF; Demacker PN; Van 't Laar A
Am J Med; 1990 Jan; 88(1N):42N-45N. PubMed ID: 2368763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
